Charles Schwab’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.9M | Sell |
1,012,555
-2,271
| -0.2% | -$58K | ﹤0.01% | 1642 |
|
|
2025
Q4 | $29.5M | Buy |
1,014,826
+15,392
| +2% | +$394K | ﹤0.01% | 1505 |
|
|
2025
Q3 | $18.8M | Buy |
999,434
+34,368
| +4% | +$542K | ﹤0.01% | 1770 |
|
|
2025
Q2 | $13.5M | Buy |
965,066
+104,298
| +12% | +$1.46M | ﹤0.01% | 1863 |
|
|
2025
Q1 | $13.5M | Sell |
860,768
-18,036
| -2% | -$254K | ﹤0.01% | 1820 |
|
|
2024
Q4 | $12.2M | Buy |
878,804
+18,958
| +2% | +$208K | ﹤0.01% | 1927 |
|
|
2024
Q3 | $8M | Buy |
859,846
+8,522
| +1% | +$84.1K | ﹤0.01% | 2142 |
|
|
2024
Q2 | $7.92M | Buy |
851,324
+100,600
| +13% | +$910K | ﹤0.01% | 2152 |
|
|
2024
Q1 | $7.44M | Buy |
750,724
+179,406
| +31% | +$1.34M | ﹤0.01% | 2133 |
|
|
2023
Q4 | $1.85M | Buy |
571,318
+187,505
| +49% | +$510K | ﹤0.01% | 2645 |
|
|
2023
Q3 | $2.04M | Buy |
383,813
+53,871
| +16% | +$458K | ﹤0.01% | 2593 |
|
|
2023
Q2 | $3.14M | Buy |
329,942
+27,440
| +9% | +$305K | ﹤0.01% | 2413 |
|
|
2023
Q1 | $3.33M | Buy |
302,502
+774
| +0.3% | +$11.2K | ﹤0.01% | 2372 |
|
|
2022
Q4 | $4.47M | Buy |
301,728
+10,635
| +4% | +$186K | ﹤0.01% | 2272 |
|
|
2022
Q3 | $5.56M | Buy |
291,093
+73,833
| +34% | +$1.67M | ﹤0.01% | 2161 |
|
|
2022
Q2 | $4.63M | Buy |
217,260
+16,296
| +8% | +$334K | ﹤0.01% | 2216 |
|
|
2022
Q1 | $3.87M | Buy |
200,964
+2,511
| +1% | +$42.5K | ﹤0.01% | 2395 |
|
|
2021
Q4 | $4.12M | Buy |
198,453
+2,616
| +1% | +$52.1K | ﹤0.01% | 2445 |
|
|
2021
Q3 | $4.68M | Buy |
195,837
+2,455
| +1% | +$56K | ﹤0.01% | 2410 |
|
|
2021
Q2 | $5.28M | Buy |
193,382
+13,702
| +8% | +$386K | ﹤0.01% | 2324 |
|
|
2021
Q1 | $5.2M | Buy |
179,680
+38,241
| +27% | +$1.19M | ﹤0.01% | 2284 |
|
|
2020
Q4 | $3.98M | Buy |
141,439
+30,816
| +28% | +$755K | ﹤0.01% | 2333 |
|
|
2020
Q3 | $3.24M | Buy |
110,623
+42,377
| +62% | +$1.13M | ﹤0.01% | 2296 |
|
|
2020
Q2 | $2.06M | Buy |
68,246
+46,225
| +210% | +$1.34M | ﹤0.01% | 2415 |
|
|
2020
Q1 | $657K | Buy |
+22,021
| New | +$592K | ﹤0.01% | 2614 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
